Dr. John Villano, MD, PhD
Claim this profileUniversity of Kentucky/Markey Cancer Center
Studies Cancer
Studies Brain Tumor
20 reported clinical trials
36 drugs studied
About John Villano, MD, PhD
Education:
- Holds an MD (Doctor of Medicine).
- Earned a PhD (Doctor of Philosophy).
Experience:
- Serves as a Medical Oncologist specializing in brain cancer treatment at the University of Kentucky/Markey Cancer Center.
- Active member of the Medical Oncology Division at Markey Cancer Center, recognized as a Comprehensive Cancer Center by the National Cancer Institute.
- Engages in teaching medical students, residents, and fellows at the Markey Cancer Center.
Area of expertise
1Cancer
Stage IV
Stage III
NF1 positive
2Brain Tumor
Stage IV
IDH positive
1p/19q co-deletion positive
Affiliated Hospitals
Clinical Trials John Villano, MD, PhD is currently running
Lomustine + Standard Therapy
for Glioblastoma
This phase III trial compares the effect of adding lomustine to temozolomide and radiation therapy versus temozolomide and radiation therapy alone in shrinking or stabilizing newly diagnosed MGMT methylated glioblastoma. Chemotherapy drugs, such as lomustine and temozolomide, work in different ways to stop the growth of tumor cells, either by killing the cells, by stopping them from dividing, or by stopping them from spreading. Radiation therapy uses high energy photons to kill tumor cells and shrink tumors. Adding lomustine to usual treatment of temozolomide and radiation therapy may help shrink and stabilize glioblastoma.
Recruiting2 awards Phase 34 criteria
Selinexor + Temozolomide
for Recurrent Glioblastoma
This trial tests selinexor with temozolomide for patients whose brain cancer has returned. Selinexor blocks a protein that helps cancer cells grow, and temozolomide damages their DNA to kill them or stop their growth. Temozolomide is a DNA methylating drug currently used as a first-line treatment in glioblastoma therapy.
Recruiting1 award Phase 1 & 2
More about John Villano, MD, PhD
Clinical Trial Related5 years of experience running clinical trials · Led 20 trials as a Principal Investigator · 9 Active Clinical TrialsTreatments John Villano, MD, PhD has experience with
- Pembrolizumab
- Radiation Therapy
- Nivolumab
- Temozolomide
- Paclitaxel
- Pemetrexed
Breakdown of trials John Villano, MD, PhD has run
Cancer
Brain Tumor
Non-Small Cell Lung Cancer
- Pilot Immunotherapy Study With Letetresgene Autoleucel (Lete-cel, GSK3377794)T-cells in New York Esophageal Squamous Cell Carcinoma-1 (NY-ESO-1)/ LAGE-1a-positive Advanced Non-small Cell Lung Cancer (NSCLC) Either Alone or in Combination With Pembrolizumab
- Radiation + Immunotherapy for Non-Small Cell Lung Cancer
- Radiation + Immunotherapy for Non-Small Cell Lung Cancer
Tumors
- Pilot Immunotherapy Study With Letetresgene Autoleucel (Lete-cel, GSK3377794)T-cells in New York Esophageal Squamous Cell Carcinoma-1 (NY-ESO-1)/ LAGE-1a-positive Advanced Non-small Cell Lung Cancer (NSCLC) Either Alone or in Combination With Pembrolizumab
- Targeted Therapy for Brain Cancer
- Telaglenastat for Cancer
Lung Cancer
- Pilot Immunotherapy Study With Letetresgene Autoleucel (Lete-cel, GSK3377794)T-cells in New York Esophageal Squamous Cell Carcinoma-1 (NY-ESO-1)/ LAGE-1a-positive Advanced Non-small Cell Lung Cancer (NSCLC) Either Alone or in Combination With Pembrolizumab
- Pembrolizumab + Chemotherapy for Brain Metastases from Lung Cancer
- Radiation + Immunotherapy for Non-Small Cell Lung Cancer
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does John Villano, MD, PhD specialize in?
John Villano, MD, PhD focuses on Cancer and Brain Tumor. In particular, much of their work with Cancer has involved Stage IV patients, or patients who are Stage III.
Is John Villano, MD, PhD currently recruiting for clinical trials?
Yes, John Villano, MD, PhD is currently recruiting for 9 clinical trials in Lexington Kentucky. If you're interested in participating, you should apply.
Are there any treatments that John Villano, MD, PhD has studied deeply?
Yes, John Villano, MD, PhD has studied treatments such as Pembrolizumab, Radiation Therapy, Nivolumab.
What is the best way to schedule an appointment with John Villano, MD, PhD?
Apply for one of the trials that John Villano, MD, PhD is conducting.
What is the office address of John Villano, MD, PhD?
The office of John Villano, MD, PhD is located at: University of Kentucky/Markey Cancer Center, Lexington, Kentucky 40536 United States. This is the address for their practice at the University of Kentucky/Markey Cancer Center.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.